Sorrento to Present New Data on Advanced Immunotherapies at Multiple Upcoming Scientific Conferences

NEXT STORY
Innate Pharma to share new long-term data on Lumoxiti at 2019 American Society of Hematology annual meeting
PREV STORY
ADMA Biologics Reports Third Quarter 2019 Financial Results and Highlights Recent Company Progress
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Gene Therapy Market Report 2020: Market is Expected to Recover and Reach $6.84 Billion in 2023 – Forecast to 2030

author_avatar
NASDAQ Market News

Adaptive Biotechnologies Included in More than 20 Abstracts at ASCO and EHA 2021 Highlighting Expanding Use Cases for MRD Testing with the clonoSEQ® Assay in Blood Cancer Patients

author_avatar
NASDAQ Market News

Incysus Therapeutics Scientific Co-Founder Lawrence Lamb, PhD to Present at 8th International Gamma-Delta T Cell Conference

Symposium Title: “Targeting of chemotherapy-induced NKG2DL by localized repetitive γδ T cell infusions: a ...

author_avatar
NASDAQ Market News